Anthropometric characteristics of top-class Kenyan marathon runners.

AIM: This study aims to: 1) describe the current anthropometric profiles of Kenyan marathon runners and 2) establish a set of reference values useful for future investigations on athlete selection, talent identification, and training programme development. METHODS: The participants were 14 male top-class Kenyan marathon runners (mean [s] age 27.71 [3.75] yrs, height 171.21 [6.12] cm, body mass 57.71 [4.02] kg, marathon personal best 02h 07min 16s (01min 55s); training volume: 180-220 km·wk-1; high:low intensity training ratio: 1:2). The anthropometric profiles included the measurement of skinfolds, and segment lengths, breadths, and girths. To estimate body density (BD) multiple regression equations were calculated using the sum of 7-skinfolds method and then converted to percentage of body fat (%BF). The somatotype, somatotype dispersion mean (SDM), somatotype attitudinal mean (SAM), and height to weight ratio (HWR) as well as the skinfolds extremity to trunk ratio (E:T) were also calculated. RESULTS: The mean (s) of BD, %BF, SDM, SAM, HWR and E:T were 1.13 (0.02), 8.87 (0.07) %, 4.58 (3.62), 0.51 (0.09), 44.32 (1.06), and 0.36 (0.11), respectively. The mean (s) endomorphy, mesomorphy, and ectomorphy were 1.53 (0.32), 1.61 (1.81), and 3.86 (0.78), respectively. CONCLUSION: Top-class Kenyan marathon runners seem to have ectomorphy as dominant, with endomorphy and mesomorphy more than one-half unit lower. Despite population comparisons would be required to identify any connection between specific anthropometric dimensions, these reference data should be useful to practitioners and researchers, providing useful information for talent identification and development and for the assessment of training progression in marathon.

[Clinical-therapeutic considerations in pertussis]. / Considerazioni clinico-terapeutiche sulla pertosse.

One-hundred and seventy-one cases of pertussis were observed at the Institute of Infections Diseases and at the 2nd Division of Infectious Diseases of the Policlinico Umberto I in Rome from January 1, 1987 to June 30, 1991. All subjects were treated according to a therapeutic protocol consisting of macrolides (erythromycin or myocamicin) at doses of 40-50 mg/die, betamethasone 0.1 mg/kg/die, specific immunoglobulin G at doses of 0.5 ml/kg repeated after 24 hours (new born babies and babies still unweaned) and oxygen therapy during the paroxystic fits. In 20 patients who were over the first year of life and who had serious asphyxiated fits, bronchodilators (trimetochinol or salbutamol) were added to the previous therapeutic scheme. Our data show both efficacy of therapeutic protocol and importance of early starting the treatment to shorten the length of disease, the strength of asphyxiated fits, and the risk of contagion.